Used in research as a heat shock protein 90 (Hsp90) inhibitor, helping to study cancer cell signaling and protein folding pathways. Shows potential in anticancer studies due to its ability to destabilize oncogenic client proteins. Modified for improved solubility and reduced toxicity in preclinical drug development. Investigated for use in targeted therapies, particularly in tumors dependent on Hsp90 for survival. Also applied in cellular stress response experiments to modulate chaperone activity.